CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases - Wikidata - awgldk - TriplyDB

CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases

CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases

http://www.wikidata.org/entity/Q37208032

about

Common variants of the vitamin D binding protein gene and adverse health outcomes The ageing systemic milieu negatively regulates neurogenesis and cognitive function.The role of orexin in post-stroke inflammation, cognitive decline, and depression Chemokine receptor CXCR2: physiology regulator and neuroinflammation controller?Biochemical premotor biomarkers for Parkinson's disease Emerging candidate biomarkers for Parkinson's disease: a review Inflammation and α-synuclein's prion-like behavior in Parkinson's disease--is there a link?β2-microglobulin is a systemic pro-aging factor that impairs cognitive function and neurogenesis Biomarkers for cognitive impairment and dementia in elderly people.Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression The role of biomarkers and imaging in Parkinson's disease.Cerebrospinal fluid concentration of brain-derived neurotrophic factor and cognitive function in non-demented subjects.Glycoproteomics in neurodegenerative diseases.Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease.Exploring the potential of the platelet membrane proteome as a source of peripheral biomarkers for Alzheimer's disease.PUTATIVE CSF PROTEIN BIOMARKER CANDIDATES FOR AMNESTIC MILD COGNITIVE IMPAIRMENT Biomarkers for cognitive impairment in Parkinson disease.Identification of peripheral inflammatory markers between normal control and Alzheimer's disease.Cerebrospinal fluid biomarkers in mild cognitive impairment and dementia CSF xanthine, homovanillic acid, and their ratio as biomarkers of Parkinson's disease.Using 'omics' to define pathogenesis and biomarkers of Parkinson's disease.Biomarker discovery in neurodegenerative diseases: a proteomic approach.Cerebrospinal fluid biomarkers in parkinsonian conditions: an update and future directions Cerebrospinal fluid proteomic patterns discriminate Parkinson's disease and multiple system atrophy.CSF Aβ(42) and tau in Parkinson's disease with cognitive impairment.Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease.Unbiased approaches to biomarker discovery in neurodegenerative diseases Correlation between decreased CSF α-synuclein and Aβ₁₋₄₂ in Parkinson disease.Amyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer's disease Cerebrospinal fluid biomarkers and cognitive performance in non-demented patients with Parkinson's disease.Synaptic therapy in Alzheimer's disease: a CREB-centric approach.Modeling of pathological traits in Alzheimer's disease based on systemic extracellular signaling proteome.Biomarker candidates of neurodegeneration in Parkinson's disease for the evaluation of disease-modifying therapeutics Proteomic analysis of cerebrospinal fluid in canine cervical spondylomyelopathy.Cerebrospinal fluid Aβ42 levels and APP processing pathway genes in Parkinson's disease.Age-dependent changes in the cerebrospinal fluid proteome by slow off-rate modified aptamer array Cerebrospinal fluid biomarkers of central catecholamine deficiency in Parkinson's disease and other synucleinopathies.Decreased IL-8 levels in CSF and serum of AD patients and negative correlation of MMSE and IL-1β.Group comparison of spatiotemporal dynamics of intrinsic networks in Parkinson's disease.An indicator cell assay for blood-based diagnostics.

P2860

Q24596671-89512386-58DF-49FE-BE27-5003DA21DDE3 Q24599219-918DF21C-ACC5-4B58-959F-2DA52D02F55D Q26851982-56361057-64B3-4D46-AD1C-B666F9C6BDDD Q27007078-32CD17F2-4959-43C3-B4A5-8BEECC40794F Q27008467-7A56484E-2A83-41BF-BCF3-B0F343A40958 Q27015018-F9DB888D-3CB0-4872-8B5E-36AE22623EEF Q27022728-C32CE7E8-9969-4CE7-B7B4-3410001698B7 Q27315300-DF78BC9A-0B11-40EA-9ED7-BC531A8A9B7E Q30370745-8DDE2AB6-7CA0-4929-8604-037DA307C687 Q30501271-3AF615C8-FC58-4D55-AED9-94DD05698B3D Q31041660-913CE6A5-3925-472D-AA9D-B8289AFE68DD Q33438465-17C50CCA-C666-43F6-BA00-57A37730A6A9 Q33563387-05329D08-1DDB-44CB-9673-51C98EA5B2B0 Q33666297-8ED0988C-DCD5-4E53-9BBA-5691D81D7214 Q33745920-BFFC1219-EF22-4C42-919A-4229C44F08F0 Q33818120-33092141-BDEB-435E-A029-8C8AA1E7CC4A Q33896664-D79F2AF0-9022-49E5-AFB7-F83FEC5C93F9 Q33898749-998A4A16-A9C8-4107-A1CB-A587A1A7EDF3 Q33936708-A88E8B6D-BB7A-40F8-AE1B-A68D0525F02A Q33994583-D8FA8BF3-B583-48F0-B315-78A774311A5D Q34032608-410CBE6D-6492-4BAC-BBD2-C5DD3A3835F5 Q34125681-3B3D8850-210B-4BC6-BC48-5A8784CBA0D3 Q34237637-78657BA2-70C8-4698-BCAC-BEEFEE3DC3A7 Q34295261-736B7F6D-6859-4A5F-A29A-C7D27BCB4DB4 Q34299993-85BB1F49-5D2A-4F2C-B1DD-CD63CE13B9B6 Q34315258-E525CB38-373B-4C20-868D-10ECF2BB6A39 Q34625918-728270B5-8010-49DE-92B0-CB72EB3CC4FD Q34714560-19A130EC-B972-47FE-B9D4-DAC39302E6D8 Q34728911-A9540068-2AFD-4E73-9001-8085B12EE6FA Q34766509-9A54645E-1376-4876-902E-125803527114 Q35064948-A0AA21D4-BDB8-45E6-96F9-4AD5203EF487 Q35497573-294CD9F1-75B5-40CF-94ED-0F3A4025AD4B Q35649302-DC5E3A8B-0C1F-4702-9163-C608EE29469B Q35672528-44EB6D77-D3A2-42BE-B4F6-E89243B8F645 Q35772659-88B33487-0D6F-40EE-89CB-088670782A5D Q35951935-033D8F26-3950-4B4D-B2C4-E68CF1F78C45 Q35986671-783C8D3E-B8EA-4335-B596-20C790B07DF1 Q36145503-DF79EDC6-ADA4-40EE-A3DE-CC206C35B7A6 Q36276502-D5D84620-2794-4428-B52F-FBA6911F6755 Q36395874-077BDBEE-DE7E-4767-A139-8A939D2B42CA

P2860

CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases

http://www.wikidata.org/entity/Q37208032

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases

@en

CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases.

@nl

type

label

CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases

@en

CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases.

@nl

prefLabel

CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases

@en

CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases.

@nl

P1433

Q37208032-3D1538A9-ABDD-4BC2-83E2-6C0240FEB164

P1476

Q37208032-8B8261FB-C38F-40B0-8D0E-B4A6A6DB1DAF

P2093

Q37208032-23160FAA-9DAD-4BA0-9361-4351D285D35A

Q37208032-2364BFE7-4A06-4D19-B227-99C7AA259F5E

Q37208032-30BFDF98-2E03-4EDD-8944-D5CE31FA76EE

Q37208032-34D962C5-595E-4519-B676-741F8413805C

Q37208032-5C4CA86B-51A2-4876-A9CE-5165357519FF

Q37208032-897112DF-74B2-4664-8A6D-EB4B2C24D05C

Q37208032-D8D9A5A1-CE75-4109-8B51-C1EB91CCD948

Q37208032-E8E56F3F-4422-4A38-AF9B-5FBA13538246

P2860

Q37208032-38B3B9C7-6DC7-40ED-854A-3E7759F46FDB

Q37208032-3ADA9BA0-A6A2-4F38-91CA-33DD8FE75711

Q37208032-3F835CAF-B5EF-4369-BB3A-F7C1B787D65D

Q37208032-50F14BE8-3A72-497D-80A3-7930776E4692

Q37208032-5B2E249D-5DA4-4C8B-BFD5-337EDCAF8263

Q37208032-6BDEF2DE-DA2E-4B1D-818C-6F963EC4BAC9

Q37208032-74B0D347-26FB-41BF-99BE-F8E7691A7977

Q37208032-882FDCFC-1758-43BB-816C-6F066676C365

Q37208032-97A5762A-BA67-4ED6-9E1A-FBA8E0000DC4

Q37208032-A357A65D-D4F4-4A15-9421-8306ED85C5CE

P304

Q37208032-88F769C2-FED0-4AF5-9517-077FA78FF33C

P31

Q37208032-01DD3DF7-CE1A-4481-AD50-CFA3E8D70DEC

P356

Q37208032-1B2C72AA-C5F3-430D-8B17-5E890DBE2311

P407

Q37208032-D00440E3-6371-45FB-B9D8-76BA0E359251

P433

Q37208032-EC27FFCC-DF6A-4FDD-B268-8A50F940F802

P478

Q37208032-AE816A1A-AB10-43A3-AB94-EC0E71308FAF

P50

Q37208032-7EA71161-5D2B-48AF-A27F-75185A835122

Q37208032-B8488881-7791-4041-8405-CE88FC0EC09D

P577

Q37208032-9DF3CF7C-5E4D-4F3A-A40B-E276174C1B6C

P698

Q37208032-E8C3F209-4A89-499E-B7CF-0A15D1075B13

P921

Q37208032-01281A35-F230-4FE3-B3DF-C6F36A338262

Q37208032-50D21F92-50B5-4930-AEE0-A0129DAFFC54

P932

Q37208032-EE568FB9-CCF4-4F31-98CF-D1C7AC8E2520

P356

W01Y0B808EMEH12L

P1433

American Journal of Clinical Pathology

P1476

CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases

@en

P2093

Christopher Kenney

http://www.w3.org/2001/XMLSchema#string

Elaine R Peskind

http://www.w3.org/2001/XMLSchema#string

Izabela Sokal

http://www.w3.org/2001/XMLSchema#string

Jing Zhang

http://www.w3.org/2001/XMLSchema#string

Joseph F Quinn

http://www.w3.org/2001/XMLSchema#string

Kathryn A Chung

http://www.w3.org/2001/XMLSchema#string

Steven P Millard

http://www.w3.org/2001/XMLSchema#string

Thomas J Montine

http://www.w3.org/2001/XMLSchema#string

P2860

Gene selection and classification of microarray data using random forest.

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Mild cognitive impairment: clinical characterization and outcome

Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations

Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria

Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer's disease and non-demented elderly subjects.

Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders.

Novel panel of cerebrospinal fluid biomarkers for the prediction of progression to Alzheimer dementia in patients with mild cognitive impairment.

Diagnostic criteria for Parkinson disease.

Biomarkers for Alzheimer's disease--clinical needs and application.

P304

526-529

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1309/W01Y0B808EMEH12L

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

129

http://www.w3.org/2001/XMLSchema#string

P50

Joseph Jankovic

P577

2008-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18343778

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

Parkinson's disease

P932

2688655

http://www.w3.org/2001/XMLSchema#string